US dialysis facility closures from 2018 to 2023 have raised concerns about access to vital care, especially in rural communities. Despite an increase in adults diagnosed with end-stage renal disease, there has been a decrease in facility openings. Additionally, a study found that clinicians do not consistently use algorithms for dosing methoxy polyethylene glycol-epoetin beta when treating patients with anemia. The KidneyIntelX test has shown promising results in improving hypertension in patients with diabetic kidney disease. Other topics of interest include hydralazine-induced autoimmune conditions, outcomes of chlorthalidone vs. hydrochlorothiazide among veterans, and the need to address social disparities in kidney disease care.
Source link
Top nephrology meeting news in 2024
Share This Article
